Journal of Patient-Centered
Research and Reviews
Volume 7

Issue 3

Article 3

7-27-2020

Feasibility and Validity of Asking Patients to Define Individual
Levels of Meaningful Change on Patient-Reported Outcomes
Salene M.W. Jones
Yuxian Du
Ari Bell-Brown
Kaylin Bolt
Joseph M. Unger

Follow this and additional works at: https://aah.org/jpcrr
Part of the Clinical Psychology Commons, Counseling Commons, Counseling Psychology Commons,
Diagnosis Commons, Health Psychology Commons, Health Services Research Commons, and the Other
Psychiatry and Psychology Commons

Recommended Citation
Jones SM, Du Y, Bell-Brown A, Bolt K, Unger JM. Feasibility and validity of asking patients to define
individual levels of meaningful change on patient-reported outcomes. J Patient Cent Res Rev.
2020;7:239-48. doi: 10.17294/2330-0698.1742

Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal
focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes,
and the patient experience.

ORIGINAL RESEARCH

Feasibility and Validity of Asking Patients to Define
Individual Levels of Meaningful Change on PatientReported Outcomes
Salene M.W. Jones, PhD,1 Yuxian Du, PhD,1,2 Ari Bell-Brown, MPH,1 Kaylin Bolt, MPH, MEd, MSW,3
Joseph M. Unger, PhD1
Fred Hutchinson Cancer Research Center, Seattle, WA; 2Data Generation and Observational Studies, Bayer
HealthCare LLC, Whippany, NJ; 3independent scholar
1

Purpose	Patient-reported outcomes (PROs) are frequently used in clinical care to monitor treatment response.
However, most guidelines on PRO use treat all patients the same. This study tested the feasibility and
validity of a method for determining individually meaningful change in PRO measures.
Methods

 articipants (n=398) completed 12 pain and distress questions to define individually meaningful
P
change. This mixed-methods study used both quantitative and qualitative analyses, including
descriptive statistics, inferential statistics, and content analysis.

Results 	Two-thirds (67%) of the sample reported at least one medical condition, including depression and back
pain. Most participants (70%–90%) were able to answer the questions as intended. Participants varied
widely in the amount of change they considered meaningful (coefficients of variation: 40%–99%).
Higher symptom levels were associated with larger amounts of change considered meaningful and
with greater likelihood of answering questions as intended. Participants reported a variety of reasons
for why they considered an amount of change in pain or distress meaningful. The hypothetical nature
of the questions and the need to reference previous questions was found to be confusing.
Conclusions

 sking patients to define an individual level for meaningful change on PROs was feasible and valid.
A
Having patients define their own goals on PROs for treatment of pain or distress could make treatment
more patient-centered. (J Patient Cent Res Rev. 2020;7:239-248.)

Keywords	
patient-reported outcomes; minimal clinically important difference; treatment response; mixed methods;
qualitative; quantitative; pain; distress

P

atient-reported
outcomes
(PROs)
are
questionnaire-based measures of a patient’s
perception of their current health state.1 PROs
are frequently used in measurement-based care
(MBC), an approach in which patients are monitored
to ensure treatments are working or if treatment
needs to be changed.2-5 Determining the amount of
change needed to classify a treatment as working or
not working in MBC has been challenging. Previous
work has focused on defining the minimally important
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difference (MID), which is the smallest amount of
change between two groups necessary to consider
a treatment successful.6-9 Other work has focused
on defining statistically significant or noticeable
change at the individual, rather than group, level.10,11
However, these approaches differ from the original
definition of the MID, which is the smallest amount
of change that is meaningful to the individual patient
and would warrant a change in treatment.12
The need for some measure of what is meaningful
to each individual patient, rather than changes
between groups or statistical significance, has been
acknowledged.13-18 Personalizing the items on PROs
makes them more sensitive to treatment effects,19
suggesting that personalizing the amount of change
www.aah.org/jpcrr
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considered meaningful could also improve treatment
and MBC. Patients differ from each other in what they
consider a meaningful change on a PRO,20 yet the
only current options for determining whether patients
improved a meaningful amount use group-based MID
to assess individual patients (eg, a 5-point change is
considered meaningful for all) or to look for statistically
significant change that might not be meaningful. Recent
methods of determining a group-based MID have
involved asking patients and providers to review case
reports and judge whether one is worse than the other
or, for patients, whether the case had worse symptoms
than their own,20,21 showing that patients can report
directly what they consider meaningful. However,
these methods were cognitively burdensome and did
not reference changes in the patient’s own health state.
Rather than creating an omnibus MID that is applied
to all patients equally, methods for determining what
is individually meaningful to each patient are needed.
This study tested the feasibility of a new method of
determining individually meaningful change on PROs
using a prospective approach. We chose a prospective
approach, as previous attempts at retrospective
approaches have had problems.22,23 Previous attempts to
create measures of PRO change that is meaningful to
the individual patient have involved significant clinician
effort and input.24,25 Our proposed method, simply asking
patients to define for themselves what is meaningful,
would be less burdensome and, surprisingly, has not
been tested yet. If proved feasible and valid, it could
help make MBC more patient-centered by using the
amount of change meaningful to the individual patient
as the marker of whether a treatment is working or not.
We examined feasibility both in a general sample
and also in people reporting pain, distress, back pain,
or depression. As participants with higher symptom
levels have more room to change, we examined
validity of the new method through association of
the amount of change considered meaningful with
current symptom level.

METHODS

Participants and Procedures
Participants were recruited from Prolific Academic,
a crowdsourcing website that helps connect potential
study participants with online research studies.
Participants had to be 18 years of age or older and able
240 JPCRR • Volume 7, Issue 3 • Summer 2020

to read and write English. Once the study was posted on
Prolific Academic, potential participants either checked
the website periodically or received notification that a
study was available. They then went to the website and
completed the survey. Participants received $8.00 after
survey completion. All participants provided informed
consent, and the study was reviewed and approved by
the institutional review board (#8703).
Measure
The numerical rating scale (0=no pain or distress,
10=worst pain or distress) was used because of
its ubiquity and likely familiarity to all patients.26
Patients were first asked to rate their current levels
of pain or distress. A set of 5 questions (Table 1) was
drafted to ask participants about the amount of change
considered meaningful, either in general or in response
to treatment. Each set of 5 questions was asked per
construct (pain and distress), along with the numerical
rating scale for that construct, resulting in a total of
12 questions. The research team, colleagues, and a
paid patient consultant reviewed the questions and
made revisions. After each of the 10 drafted questions,
participants were asked to provide a brief explanation
of the reasons for each answer.
Quantitative Analyses
We examined two quantitative outcomes per question:
paradoxical vs logical responding; and amount
of change. Paradoxical vs logical responding was
considered a measure of feasibility as it showed
how many participants could answer the questions
as intended. Individual meaningful change for pain
or distress worsening was defined as the difference
between current pain or distress and the level indicating
worsening. For pain or distress worsening, an answer
was defined as paradoxical if the person marked a level
of pain or distress at or below their current level (ie, the
difference was negative or zero). Individual meaningful
change for pain or distress improving was defined as the
difference between current pain or distress and the level
indicating improvement. For pain or distress improving,
an answer was defined as paradoxical if the person
marked a level of pain or distress at or above their
current level (ie, the difference was negative or zero).
We also calculated the difference in the level at which
one would want treatment and the levels at which one
would consider a treatment working or successful. For
Original Research

Table 1. Survey Questions for Determining Individually Meaningful Change*
Q1. In the past 7 days, how would you rate your [pain/distress] on average?
Q2. Given your current [pain/distress] level, what level on this question would mean your pain was getting worse?
(Pain/Distress Worsen)
Q3. Given your current [pain/distress] level, what level on this question would mean your pain was getting better?
(Pain/Distress Improve)
Q4. On this 0 to 10 scale, at what level would you want treatment for your [pain/distress]?
If you were experiencing a high level of pain and received treatment for [pain/distress] …
Q5. … what level on this question would mean this treatment was working? (Pain/Distress Treatment Work)
Q6. … what level would your [pain/distress] have to be to consider the treatment a success? (Pain/Distress Treatment Success)
*Questions 2 and 3 were used in conjunction with Question 1 to determine meaningful level of change. Questions 4 and 5
were used in conjunction with Question 6 to determine a different metric of meaningful change.

a treatment working or being a success, an answer
was defined as paradoxical if the person marked an
answer at or above the level they marked for wanting
treatment (ie, treatment is working if pain or distress
had increased). For amount of change, we examined
the difference between their numerical rating scale
answer for current pain or distress and the amount of
change for worsening or improving symptoms. We also
examined the difference between the level at which
one wanted treatment and the change constituting
treatment working or successful.
To examine feasibility, we calculated the frequency
of paradoxical responding by each question and for
the following subgroups: participants reporting back
pain; participants reporting depression; participants
experiencing pain in the past 7 days; and participants
experiencing distress in the past 7 days. Feasibility was
determined by the proportion of respondents answering
questions as intended. To assess validity, we also used
logistic and linear regressions to test the association of
current level of pain/distress to the level at which one
would want treatment, with paradoxical responding
and amount-of-change considered meaningful.
Analyses controlled for demographic variables, and
demographics were included based on significant
associations with the outcomes. First, each demographic
variable was tested for a univariate association with
the 8 paradoxical responding outcomes and 8 amountof-change outcomes. Demographic variables with
P-values of <0.25 in the univariate analyses were then
entered into a multivariate regression. Lastly, the final
multivariate regression was run using only significant
Original Research

variables from the previous multivariate regression.
The following demographic variables were tested: age,
gender, income, race/ethnicity, education, living in
the United States, hypertension diagnosis, depression
diagnosis, and back pain diagnosis.
Qualitative Analyses
Responses to the questions asking for the reasons were
coded by members of the research team using qualitative
content analysis. The codebook was developed
inductively; the first coder read all the statements of
all the surveys and developed a preliminary codebook
based on the codes that emerged. The first coder then
trained the second coder on the codebook and the two
independently applied the codes to the first 25 records.
The two coders discussed major discrepancies and
applied agreed-upon revisions to the codebook. They
then independently coded the next 75 records (records
26 to 100) and again discussed major discrepancies,
resulting in a further refined and consolidated codebook.
The first 25 and next 75 records were chosen because
this allowed enough variability to inform changes to
the codebook but also enough additional records to
test the revisions. The two coders then independently
coded the remaining 298 records.
A third coder used the final codebook to reconcile the
two independent sets of codes for all 398 records.

RESULTS

We originally recruited 400 participants, but 2 did not
successfully answer 3 or more of the 4 attention check
questions, resulting in a final sample of 398. Consistent
with previous studies using Prolific samples, the study
www.aah.org/jpcrr
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sample was predominantly college-educated and from
Europe (Table 2). Two-thirds (67%) of the sample
reported at least one medical condition, including
depression, high blood pressure, back pain, and arthritis.
Means for what participants considered meaningful
are reported in Table 3. The standard deviations
for meaningful PRO change were relatively large
(coefficients of variation ranging from 40% to 99% in
the total sample), indicating participants had differing
views of what constituted a meaningful change.
Paradoxical Responding
The frequency of paradoxical responding to the
individually meaningful change questions is reported
in Table 3. The percentage of participants reporting a
paradoxical response (answering the questions not as
intended), including missing responses, ranged from

Table 2. Demographics of the Study Sample (N=398)
Characteristic

n (%) or
mean (SD)

Age in years, mean (SD)

33.10 (12.07)

Gender, n (%)
Female
Other gender
   Declined to answer
Male

234 (58.8%)
3 (0.8%)
3 (0.8%)
158 (39.7%)

Race/Ethnicity,* n (%)
   White
Hispanic
Asian
Black
Multiracial

372 (93.5%)
12 (3.0%)
19 (4.8%)
18 (4.5%)
16 (4.0%)

Yearly income in U.S. dollars, mean (SD)

$31,689
($34,654)

Education, n (%)
   High school diploma, GED or lower
   Some college or associate’s degree
   Bachelor’s degree
Graduate degree

88 (22.1%)
141 (35.4%)
116 (29.1%)
53 (13.3%)

Marital status, n (%)
Married
Long-term relationship
   Single

152 (38.2%)
125 (31.4%)
121 (30.4%)

Living in United States, n (%)

70 (17.6%)

*Participants were able to select more than one race/ethnicity
option, including multiracial.
SD, standard deviation.
242 JPCRR • Volume 7, Issue 3 • Summer 2020

10% to 30%. Questions about individually meaningful
change for pain or distress worsening or what level
would mean the treatment was working tended to
have higher levels of paradoxical responding. Most
participants (76%) were able to answer 6 to 8 of the
questions as intended. Rates of paradoxical responding
were consistent across patient groups.
Demographic variables associated with nonparadoxical
responding are reported in Table 4. People with higher
education were more likely to answer questions as
intended when asked about what constituted a worsening
of symptoms than people with a high school diploma
or less. As was expected, people reporting more pain or
distress were more likely to answer questions as intended
compared to people reporting less pain or distress. The
two exceptions were: higher initial pain level was found
to be associated with more paradoxical responding for
pain treatment working; and higher initial pain levels
was associated with higher likelihood of paradoxical
response on treatment being a success.
Level of Individually Meaningful Change
Results of the regressions comparing demographics,
symptom levels, and levels at which one wanted
treatment are reported in Table 5. Higher current pain
or distress levels were associated with larger amounts
of improvement (higher pain level, larger decrease in
pain to be considered an improvement) but smaller
amounts for worsening of pain or distress (higher
pain level, smaller increase in pain to be considered
worsening). People with a higher level of pain or
distress at which they wanted treatment tended to
want larger decreases in pain or distress to consider
treatment working or successful. Few demographic
variables were associated with level of change
considered meaningful, but being non-Hispanic was
associated with considering smaller changes in distress
meaningful compared to Hispanic participants.
Qualitative Results
Results from the qualitative analysis of reasons
participants considered certain amounts meaningful
showed 4 general categories of reasons: amount; context
outside of pain or distress; context specific to pain or
distress; and confusion about answering the questions.
Each theme had 4 to 9 subthemes (child codes). Two of
the subthemes from context outside of pain or distress
were further divided into 3 or 4 grandchild codes (see
Original Research

8%
14%
23%
21%
--69%
54%
52%
45%
44%
2.13 (1.46)
1.84 (1.00)
3.59 (1.85)
4.88 (2.21)
6.21 (2.72)
10%
10%
23%
21%
--69%
60%
53%
44%
40%

CoV, coefficient of variation; Para, paradoxical response; SD, standard deviation.

11%
16%
25%
24%
--68%
60%
54%
45%
48%
2.13 (1.44)
1.93 (1.16)
3.57 (1.93)
4.82 (2.18)
5.96 (2.85)
11%
15%
27%
23%
--68%
61%
57%
50%
47%
2.32 (1.57)
1.93 (1.18)
3.48 (1.97)
4.85 (2.41)
6.12 (2.87)
12%
20%
25%
21%
--1.64 (1.57)
1.60 (1.28)
2.78 (2.21)
3.91 (2.73)
5.90 (2.87)
Distress level
Improvement
Worsening
Treatment working
Treatment successful
Level want treatment
for distress

96%
80%
79%
70%
49%

1.42 (1.40)
1.39 (1.31)
2.25 (2.05)
3.23 (2.49)
5.13 (2.70)
Pain level
Improvement
Worsening
Treatment working
Treatment successful
Level want treatment
for pain

*The percentage of respondents with a paradoxical response included those who did not answer.

1.82 (1.30)
1.82 (1.11)
3.18 (1.83)
4.11 (2.08)
5.32 (2.65)
14%
14%
28%
21%
--74%
59%
51%
48%
47%
1.90 (1.40)
1.80 (1.07)
3.24 (1.66)
4.15 (1.99)
5.51 (2.59)
13%
19%
26%
18%
--72%
55%
57%
50%
46%
1.84 (1.33)
1.77 (0.97)
3.17 (1.81)
4.18 (2.09)
5.48 (2.52)
11%
13%
24%
16%
--72%
58%
57%
53%
43%
2.05 (1.48)
1.73 (1.01)
3.31 (1.88)
4.27 (2.28)
5.82 (2.52)
14%
27%
25%
16%
--99%
94%
91%
77%
53%

Amount: Most participants reported that
some change was meaningful to them and
should be taken seriously even if the change
was small. Other participants cited only a
large change would be meaningful either
because their pain or distress fluctuated
or because side effects of treatment could
only be justified by a large change. For
improvements and considering a treatment
successful or working, some participants
specifically said they wanted no pain or
distress. Others cited a set level of pain
or distress as constituting worsening or
improvement, including that some pain
or distress may be inevitable given their
situation.

2.30 (1.59)
1.92 (1.16)
3.43 (1.81)
4.88 (2.13)
6.48 (2.58)

71%
61%
58%
51%
50%

16%
17%
30%
21%
---

Para
CoV
Mean (SD)
Para
CoV
Mean (SD)
Para
CoV
Mean (SD)
Para
CoV
Mean (SD)
Para
CoV
Mean (SD)

People with distress in
past 7 days (n=329)
People with depression
(n=178)
People with pain in
past 7 days (n=330)
People with back pain
(n=153)
Total sample (N=398)

Depression, and Any Current Distress

Table 3. Distribution of Meaningful Change and Paradoxical Responding* for the Total Sample and Subsamples With Back Pain, Any Current Pain,

Original Research

Table 6 for example quotes and number of
participants reporting each category).

Context Outside of Pain or Distress:
Participants mentioned activities in their daily
lives, such as exercising too much or losing
a job, as a reference for how they answered
at the time of the survey. Others cited
specific medical conditions like migraines
or anxiety. Participants also mentioned
specific treatments they would consider,
had used previously, or were already taking.
Some comments about treatment were more
general and did not cite a specific treatment.
Several participants stated they did not
want treatment, usually in response to the
treatment-specific personal MID questions.
Reasons for not wanting treatment included
a desire to manage their pain or distress
on their own, such as not wanting to take
available resources from others or thinking
doctors could not help. Other reasons for
not wanting treatment were drawbacks of
treatment, a general belief that treatments
don’t work, and a belief that treatments do
not address the root cause of pain or distress.
When discussing reasons for not wanting
treatment, participants referenced specific
treatments like medication.
Context Specific to Pain or Distress:
Several participants referenced their
www.aah.org/jpcrr
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Table 4. Logistic Regression Results for Answering the Question as Intended*
Pain
improve
Long-term relation
(not married) vs
never married

2.513‡
(0.968)

Married vs never
married

0.900
(0.336)

Previously married,
now single vs never
married

0.541
(0.355)

Declined marital
status

0.767
(1.447)

Pain
worsen

Distress
improve

Distress
worsen

Some college vs
≤high school

1.867§
(0.674)

1.369
(0.514)

Bachelor vs
≤high school

1.763
(0.642)

2.701‡
(1.161)

Master/doctorate vs
≤high school

2.897‡
(1.463)

8.575†
(6.757)

Initial pain

1.905†
(0.200)

Pain level when
treatment wanted

1.222†
(0.072)

1.195†
(0.062)

Initial distress

Pain
treatment
work

Pain
treatment
success

0.751†
(0.062)

0.787†
(0.068)

2.327†
(0.214)

2.243†
(0.200)

Distress
treatment
work

Distress
treatment
success

1.916†
(0.147)

1.816†
(0.127)

2.361†
(0.264)

Distress level when
treatment wanted

1.211†
(0.059)

1.174†
(0.072)

1.303†
(0.066)

Constant

0.272†
(0.099)

0.275†
(0.113)

0.161†
(0.066)

0.705
(0.276)

0.134†
(0.052)

0.269†
(0.088)

0.133†
(0.054)

0.219†
(0.077)

Observations

n=355

n=338

n=344

n=348

n=348

n=366

n=333

n=343

*Odds ratios are reported with standard errors in parentheses.
†

P<0.01; ‡P<0.05; §P<0.1.

previous experiences with pain or distress, such as a
previous medical diagnosis or injury. In some cases,
participants cited pain or distress as variable and that
this was why they considered only larger changes
meaningful or potentially longer lasting. Similarly,
other participants cited pain or distress as stable and that
they considered even small changes meaningful. Other
participants referenced the type or location of their
pain, such as a sprained ankle. Some participants used
the frequency of the pain or distress as a benchmark
for what they considered meaningful improvement,
worsening, or needing treatment. Other participants
used whether pain or distress was noticeable or
interfering with their function to determine meaningful
change. Innate tolerance for pain or distress was also
244 JPCRR • Volume 7, Issue 3 • Summer 2020

cited. Some participants noted that their pain or distress
was already at the top or bottom of the scale.
Confusion: The qualitative analysis revealed several
ways the participants found the questions confusing.
Some did not understand the question asking for their
reasons, even if they may have understood the personal
MID questions. A few gave contradictory reasons.
Others specifically contradicted the level of pain or
distress they had reported, such as saying they had no
pain or distress but marking a 4. Several participants
did not understand the hypothetical, prospective nature
of the questions. A few participants reversed the scales,
assuming 10 was no pain or distress. A few participants
also misinterpreted the questions as asking about
Original Research

Table 5. Linear Regression Results for Magnitude of Personal Minimally Important Difference*
Pain
improve

Pain
worsen

Distress
improve

Distress
worsen

Pain
treatment
work

Pain
treatment
success

Income
$
 100~$999 vs
$0~$99
$
 1k~$9999 vs
$0~$99
$
 10k~$19,999 vs
$0~$99
   $20k~$49,999 vs
$0~$99
$
 50k~$99,999 vs
$0~$99
$
 100k~$199,999 vs
$0~$99
   ≥$200k vs $0~$99

Distress
treatment
work

Distress
treatment
success

-0.799
(0,701)
-0.457
(0.371)
-0.351
(0.323)
-0.868†
(0.294)
-0.833‡
(0.348)
-0.652
(0.515)
-0.919
(1.064)

Non-Hispanic vs
Hispanic

-1.172†
(0.410)

-1.699†
(0.536)

-1.190‡
(0.548)

Declined ethnicity

2.217‡
(0.938)

0.481
(1.581)

0.252
(1.620)

-0.107†
(0.039)

-0.155†
(0.039)

0.622†
(0.052)

0.810†
(0.049)

Initial pain (0=none,
10=most)

0.342†
(0.032)

-0.065‡
(0.031)

Pain level when
treatment wanted

0.588†
(0.050)

Initial distress (0=none,
10=most)

0.303†
(0.031)

0.733†
(0.046)

-0.118†
(0.025)

Distress level (0=none,
10=most) when
treatment wanted
Male vs female

-0.488‡
(0.193)

Other gender (≤10)

0.459
(0.887)

Declined gender (≤10)

0.786
(1.527)

Constant

0.628†
(0.132)

2.036†
(0.117)

1.858†
(0.444)

2.360†
(0.110)

-0.578§
(0.322)

0.252
(0.384)

1.269‡
(0.639)

1.231§
(0.661)

Observations

n=280

n=288

n=287

n=313

n=253

n=283

n=262

n=277

*Unstandardized coefficients are reported with standard errors in parentheses. People with paradoxical values were
excluded from these regressions.
†

P<0.01; ‡P<0.05; §P<0.1.

amount of change not level of pain or distress. Several
participants had difficulty connecting the MID questions
to their current pain or distress level or the level at which
they would want treatment. In some cases, participants
connected the level for treatment working or success to
their current level of distress or pain instead of the level
at which they would want treatment.
Original Research

DISCUSSION

This study tested the feasibility and validity of asking
people to define what they considered meaningful
change on pain and distress numerical rating scales.
Overall, this simple method appeared feasible, as most
respondents answered all or nearly all the questions
as intended. Higher levels of current pain or distress
www.aah.org/jpcrr
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Table 6. Qualitative Codes for Reasons Participants Considered Specific Amounts of Change Meaningful
Parent

Child

Amount

Some change (292); “Any reduction would be positive”

Grandchild

Large amount (191); “A change of 2 could be within normal ups and downs. A
change of 3 would make me worry”
No distress or pain (221); “If the treatment is successful, I should be
experiencing minimal to no pain”
Set level including some is normal or to be expected (310); “I wouldn’t expect it
to be 0 because we all get distressed but as long as it’s manageable”
Context,
outside
pain or
distress

Activities, outside events (86); “I'm quite anxious about my job and family life at
the minute”
Medical diagnosis (70); “I have MS [multiple sclerosis] so my pain threshold varies”
Medical treatment

Specific treatment (74); “At this level I would
require Advil or possibly something stronger
depending on how long the pain lasted”
Want treatment, nonspecific (150); “I need
treatment at this level”

Don't want treatment

Already taking treatment (36); “Tablets are
working so it’s great”
Manage on own (120); “I can manage the
pain on my own”
Treatment drawbacks (30); “Medications
make me sick, so it needs to be a lot of
distress before I will resort to it”
Treatments don't work (38); “I take ibuprofen
and paracetamol at this level, but they don’t
really help as I can’t sleep”
Treatments don't address root cause (13);
“Generally my distress is sourced in something
reasonable so cannot be completely removed,
but a 4 would mean it can be managed without
wasteful amounts of distress”

Context,
pain- or
distressspecific

History of pain or distress (previous experience) (111); “I have a chronic low-level
pain at around a 3 level, so back to this base level [for me]”
Type or location of pain (81); “I suffer with back pain”
Pain or distress is variable (82); “My distress is up and down”
Pain or distress is stable (54); “Pain is fairly consistent on a daily basis”
Frequency of pain or distress (81); “Lower score represents less frequent pain”
Disposition/tolerance (63); “Have a low pain tolerance”
At 0 or 10 (106); “I'm not experiencing pain right now”
Noticeable (93); “Noticeable enough to be problematic”
Interference/function (235); “That’s the level at which the pain becomes easily
manageable”

Confusion

Don't understand (115); “I was unsure what qualifies as ‘high,’ so 4 is a good
safe number to pick because it's definitely on the lesser side”
Didn't understand the reasons question (29); “Climate change”
Contradictory reasons (7); “I feel the pain I experience is not bad enough to be
treated, but is also something that should be treated”
Contradicts numerical rating scale (47); “I am currently not experiencing pain”
[marked 3 for numerical rating scale]
Didn't understand hypothetical (142); “My pain is getting better” [in response to
the question about worsening pain]
Interpreted higher as better (instead of worse) (73); “It would improve” [in
response to distress treatment working question, participant marked 8 but
marked 4 for wanting treatment for distress]
Interpreted as change not level (3); “That's the same rate of the previous
question. [Because] it's a balance... 5 for getting worse, 5 for getting better”
Didn't connect to correct numerical rating scale (146); “4 is considerably greater
than 8” [in response to the question about distress treatment success, but
participant marked 10 for wanting treatment and 8 for current distress]

Parentheses indicate number of participants reporting that code. Italicized phrases are example quotes with explanations in square brackets.
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and higher levels at which one wanted treatment were
associated with larger amounts of change considered
meaningful, suggesting this method was valid, as this
would be expected because these participants had
more range on the rating scale to change. Paradoxical
responding occurred most often for whether a
treatment would be working, but also for whether
a treatment was a success. Participants reported a
wide range of what changes in pain and distress they
considered meaningful and reported a diverse set of
reasons for what they considered a meaningful change
in pain or distress. Participants seemed to be thinking
both in level and amount of change in pain or distress.
Overall, the quantitative and qualitative results suggest
that simply considering the same amount of change as
similarly important for all patients is likely not ideal.

Limitations
The limitations of the study should be noted. This was
a convenience sample. Respondents may have been
savvier with survey questions due to being recruited
through a crowdsourcing website. However, Prolific
Academic has been used in hundreds of research
studies.27,28 Our use of attention check questions
meant careless responding was unlikely, and the
Prolific platform prevents people from completing
a survey more than once. The sample also was not
selected for previous experience with pain or distress,
although we did stratify feasibility numbers by pain,
distress, back pain, and depression. While the use of
the numerical rating scale was warranted for this first
study, these results might not translate to multi-item,
scored PROs.

Results showed a variety of reasons for what people
considered meaningful change, consistent with
previous research.20,21 Coefficients of variation were
large, and the qualitative analyses identified a large
variety of reasons people considered an amount of
change meaningful. Interference of pain or distress
in function was cited often, but participants also
mentioned frequency of symptoms, medical conditions,
and the variability of their pain or distress. While
some participants considered any change important,
others only valued large changes in distress or pain.
Our results support continued research into ways of
determining what is individually meaningful change
on a PRO within MBC.

CONCLUSIONS

The qualitative and quantitative results also suggest
several potential revisions to reduce paradoxical
responding. Revisions should emphasize the
prospective nature of the questions and eliminate the
need for respondents to reference a previous answer.
The qualitative data showed some participants would
not want treatment even if needed, either because
they were worried about side effects or did not want
to prevent others from getting care. Therefore, further
use of the question asking participants to define at what
level they would want treatment is discouraged and a
different anchor should be devised. As the questions
about treatment working had more paradoxical
responding than treatment being a success, the wording
about treatment working needs further research to
ensure patients understand the question.

Original Research

A surprisingly simple method of asking patients to
define what is meaningful change on a patient-reported
outcome could be feasible for measurement-based
care. The method also showed initial validity. Using a
patient’s own definition of meaningful change on a PRO
may help improve the effectiveness of MBC. Future
research should examine revisions to this method to
reduce paradoxical responding as well as the utility of
using individually meaningful change in MBC. Future
research is also needed to determine whether this
approach could be adapted for clinical trials.

Patient-Friendly Recap
• Patient-reported outcomes (PROs) measure
patients’ perceptions of their health and are
used to track how patients are responding to
treatment.
• Current use of PROs in clinical care assumes
the same amount of change in symptoms
must be similarly meaningful to all patients.
• The authors tested a new model that seeks
to personalize each patient’s definition of
meaningful change (ie, effective treatment).
• This method of asking patients to define the
amount of symptom change they would find
personally meaningful to them proved feasible
and valid.

www.aah.org/jpcrr
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